Analysts Set Blend Labs, Inc. (NYSE:BLND) PT at $4.88

Shares of Blend Labs, Inc. (NYSE:BLND) have earned an average rating of “Moderate Buy” from the eight research firms that are currently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, four have issued a buy rating and one has issued a strong buy rating on the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $4.8833.

A number of research analysts recently weighed in on BLND shares. Keefe, Bruyette & Woods dropped their price target on shares of Blend Labs from $4.00 to $3.75 and set a “market perform” rating on the stock in a research report on Friday, August 8th. UBS Group decreased their price objective on shares of Blend Labs from $4.00 to $3.50 and set a “neutral” rating for the company in a research note on Friday, August 8th. Wall Street Zen upgraded Blend Labs from a “sell” rating to a “hold” rating in a research note on Sunday, August 17th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Blend Labs in a report on Wednesday, October 8th. Finally, Canaccord Genuity Group reaffirmed a “buy” rating and set a $5.25 price target on shares of Blend Labs in a research report on Friday, August 22nd.

Blend Labs Stock Up 1.7%

Shares of NYSE:BLND opened at $3.23 on Friday. The business’s 50 day moving average is $3.59 and its 200 day moving average is $3.47. Blend Labs has a 12-month low of $2.63 and a 12-month high of $5.53. The stock has a market cap of $837.41 million, a price-to-earnings ratio of -21.50 and a beta of 1.24.

Blend Labs (NYSE:BLND) last issued its quarterly earnings data on Thursday, August 7th. The company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of $0.02 by ($0.05). The business had revenue of $31.52 million during the quarter, compared to analyst estimates of $31.93 million. Blend Labs has set its Q3 2025 guidance at EPS. As a group, equities research analysts expect that Blend Labs will post -0.19 earnings per share for the current year.

Insider Buying and Selling at Blend Labs

In related news, insider Nima Ghamsari sold 311,886 shares of the business’s stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $2.90, for a total value of $904,469.40. Following the transaction, the insider directly owned 5,754,051 shares of the company’s stock, valued at approximately $16,686,747.90. The trade was a 5.14% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Brian Kneafsey sold 25,000 shares of the stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $2.87, for a total transaction of $71,750.00. Following the transaction, the insider owned 696,598 shares of the company’s stock, valued at approximately $1,999,236.26. The trade was a 3.46% decrease in their position. The disclosure for this sale can be found here. Company insiders own 35.52% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Marshall Wace LLP grew its stake in shares of Blend Labs by 157.6% during the 2nd quarter. Marshall Wace LLP now owns 2,522,141 shares of the company’s stock worth $8,323,000 after acquiring an additional 1,543,220 shares during the period. Vanguard Group Inc. lifted its holdings in Blend Labs by 4.6% during the first quarter. Vanguard Group Inc. now owns 17,586,601 shares of the company’s stock valued at $58,915,000 after purchasing an additional 775,091 shares during the last quarter. Metavasi Capital LP boosted its position in Blend Labs by 15.6% during the first quarter. Metavasi Capital LP now owns 5,554,101 shares of the company’s stock worth $18,606,000 after purchasing an additional 750,000 shares during the period. Panagora Asset Management Inc. purchased a new position in shares of Blend Labs in the second quarter worth about $2,466,000. Finally, AQR Capital Management LLC raised its position in shares of Blend Labs by 84.5% in the second quarter. AQR Capital Management LLC now owns 1,629,509 shares of the company’s stock valued at $5,377,000 after purchasing an additional 746,213 shares during the period. 52.56% of the stock is currently owned by hedge funds and other institutional investors.

About Blend Labs

Blend Labs, Inc engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty.